netFormulary NHS
Coventry and Warwickshire Area Prescribing Committee
Formulary
 Search
 Formulary Chapter 5: Infection - Full Chapter
05.03.01  Expand sub section  HIV infection
05.03.01  Expand sub section  Nucleoside reverse transcriptase inhibitors
Lamivudine (Zeffix®)
(Hepatitis B)
View adult BNF View SPC online View childrens BNF
Formulary
Amber SC

Chronic Hepatitis B infection

Specialist to provide a shared care agreement as required 

 
Emtricitabine (Emtriva®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Abacavir (Ziagen®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Abacavir & lamivudine
(Kivexa®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Abacavir with dolutegravir & lamivudine
(Triumeq®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Link  MHRA update: Dolutegravir (Tivicay¥, Triumeq¥, Juluca¥): updated advice on increased risk of neural tube defects - 10/20
Abacavir with lamivudine & zidovudine
(Trizivir®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Efavirenz with emtricitabine & tenofovir disoproxil
(Atripla®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Elvitegravir with cobicistat, emtricitabine & tenofovir disoproxil
(Stribild®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Link  MHRA update: Elvitegravir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1 - 04/19
Elvitegravir, cobicistat, emtricitabine, tenofovir alafenamide
(Genvoya®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Link  MHRA update: Elvitegravir boosted with cobicistat: avoid use in pregnancy due to risk of treatment failure and maternal-to-child transmission of HIV-1 - 04/19
Emtricitabine & tenofovir alafenamide
(Descovy®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Emtricitabine & tenofovir disoproxil
(Ictastan®,Truvada®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Emtricitabine with rilpivirine & tenofovir alafenamide
(Odefsey®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Emtricitabine with rilpivirine & tenofovir disoproxil
(Eviplera®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Lamivudine (Epivir®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Rilpivirine (Edurant®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Tenofovir disoproxil (Viread)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment for HIV infection and also Chronic Hepatitis B

 

 
Link  NICE CG165: Hepatitis B (chronic)
Link  NICE TA173: Hepatitis B (chronic) - tenofovir disoproxil
Zidovudine (Retrovir®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection

 
Zidovudine & lamivudine
(Combivir®)
View adult BNF View SPC online View childrens BNF
Formulary
Red SO

Treatment of HIV infection, including prevention of maternal fetal HIV transmission

 
05.03.01  Expand sub section  Protease inhibitors
05.03.01  Expand sub section  Non-nucleoside reverse transcriptase inhibitors
05.03.01  Expand sub section  Other antiretrovirals to top
 ....
 Non Formulary Items
Didanosine capsules
(Videx®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Discontinued Medicines
Stavudine (Zerit®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Not Recommended

HIV infection in combination with other antiretroviral drugs only when other antiretrovirals cannot be used

  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Blueteq
High Cost Drug Approval System

Traffic Light Status Information

Status Description

Preferred

Clinicians are free to prescribe these drugs. They are regarded as cost effective choices which have evidence to support their use.  

Second Line

These drugs should only be prescribed in the scenarios described in the formulary after preferred drug(s) have been ruled out.  

Non Formulary

Non-formulary choice - the vast majority of a patient’s needs should be met by use of formulary preferred choices and second line options when appropriate. Therefore the Clinician should only use a non-formulary drug if this can be justified and it is recommended that all such instances are recorded in the patient record.  

Green SA

Specialist Advised – Specialists may simply advise a patient’s GP to initiate these drugs themselves after they have made an initial assessment. Note: SA drugs can be initiated by the specialist according to patient need and also depending on local commissioning arrangements which may mandate, through the contract between provider and commissioner, that all SA drugs are treated as SI.  

Green SI

Specialist Initiation - These drugs must be initiated, i.e. the first dose prescribed, by the specialist and then may be continued when appropriate by the patient’s GP following communication from the specialist.  

Amber SC

Shared Care - Responsibility for prescribing may be transferred from secondary to primary care with the agreement of an individual GP and when agreed shared care arrangements have been established. The specialist MUST stabilize the patient before asking for care to be transferred. Only specialists should initiate these drugs. Prescribing should be transferred to GPs according to an Shared Care Agreement [SCA]   

Red SO

Specialist Only - These drugs are deemed to be not appropriate for prescribing by GPs. Specialists should not ask GPs to prescribe these drugs.   

Black BL

Black Listed Medicines - These drugs are considered inappropriate for prescribing in Coventry & Warwickshire as they are either not cost-effective or of proven benefit or both.   

Not Recommended

Not Recommended - These are drugs that are not recommended for use.  

Discontinued Medicines

Discontinued medicines - These are drugs that are no longer available to prescribe   

netFormulary